Tivozanib

tivozanib · AVEO Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

33 regulatory and trial events tracked for Tivozanib, covering 2011-09-26 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers [Phase 1, Phase 2]